Hims & Her with Novo Nordisk, Hilton, PayPal: Trendtickers

00:00 Speaker A

We take a closer look at some trend kickers this morning and make it in 30 seconds. We first identify a team here between HIMS and your and Novo Nordisk. We also have income from Hilton and PayPal. First, the healthcare system merges. The pharmaceutical giant, Novo Nordisk, worked with Startup IMS and Heis to offer millions of Americans affordable obesity. From now on, consumers can bundle a HIMS and their subscription with every dose of Novo's weight loss drug, Wegovy, at a single price from $ 599 per month.

00:43 Speaker B

Yes, a big business for HIMS and theirs and for Novo. You can also see these shares for Novo by almost 24% and 3%. Hilton exceeded expectations here in the winnings. If we can come here, we will see that Hilton's profit growth increased the adjusted profit view in the first quarter and cited strong consumer demand. Hilton also predicted sales per space available, which is up to 2% compared to 204, 2024. This is below the prior estimate of an increase of 2 to 3%.

01:20 Speaker A

Yes, overall they remain optimistic about some of these growth opportunities. The CEO, Chris Nassetta, said and finally here, PayPal delivers a mixed report, the profit estimates, missed sales. The company also confirmed its full year instruction, citing macroeconomic uncertainty. Pypl shares, they see them at the beginning of the trade lower, around two tenths of percent.

01:53 Speaker B

And you can scan the QR code to track the best and worst performance shares in the session on the “Trending Tickers” page from Yahoo Finance.